Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 399 participants.
Also called NCT01187368
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 399 participants
- Sponsor
- Evaheart, Inc.
- Registry
-
NCT01187368
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Suspended
Technical summary
Registry record NCT01187368. Randomized; no masking; primary purpose treatment. Start 2020-03-31 (actual); primary completion 2027-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System
- Acronym
- COMPETENCE
- Condition
- Heart Failure
- Intervention (Device)
- EVAHEART Left Ventricular Assist System (LVAS)
- Intervention (Device)
- HeartMate 3
- Lead sponsor
- Evaheart, Inc.
Record details
- Record id
cardio:ct-nct01187368- Content hash
9fd3acebc5fc22e5f777fa7b83d8468aedae6f134d6f42328d948613923d1e7b